Irumudi BO day 7: Yash’s Toxic Replaces Film in Theatres

Yash's highly anticipated pan-Indian film Toxic has quietly stormed into single screens and multiplexes across India, pushing Ravi Teja's action drama Irumudi out of showtimes just seven days into its…

August 28, 2026
3 min read

Yash’s highly anticipated pan-Indian film Toxic has quietly stormed into single screens and multiplexes across India, pushing Ravi Teja’s action drama Irumudi out of showtimes just seven days into its theatrical run, according to a box office report published by The Times of India on Friday, August 28, 2026.

The Telugu film Irumudi reached a worldwide box office collection of Rs. 124.85 cr. on day 7, a respectable figure, but not enough to hold its slots against the Yash-starrer wave already reshaping advance bookings.

Here’s the thing: in Indian box office economics, day 7 is the make-or-break checkpoint, and Irumudi lost that race by a margin wide enough for exhibitors to swap prints.

Irumudi’s Day 7 Numbers and the Replacement Trigger

The Rs. 124.85 cr. worldwide cume, as of day 7 for Irumudi, places the Ravi Teja starrer in a comfortable mid-tier bracket for a mass Telugu action drama.

The film opened with strong numbers in Andhra Pradesh and Telangana, riding Ravi Teja’s mass pull and the genre’s dependable single-screen economics. Worth noting: Irumudi’s day 7 collection is officially confirmed in the Times of India box office report dated August 28, 2026.

Irumudi BO day 7: Yash's Toxic

Several theatre chains have already begun pulling Irumudi shows to make room for Yash’s Toxic, which carries a pan-India distribution footprint and considerably higher per-screen pricing.

That said, Irumudi has not been formally withdrawn everywhere; replacement is happening region by region, with Telugu states and Karnataka leading the swap.

Toxic’s Strategic Release Window

Yash’s Toxic, directed by Geetu Mohandas and produced under the KVN Productions and Monster Mind Creations banner, has been positioned as one of 2026’s flagship Kannada-origin pan-Indian titles.

Releasing in direct competition for screen space with a still-running Telugu mass entertainer is unusual outside of the four-week theatrical window standard.

Distributors routinely prioritise the film with the sharper weekday curve, and Toxic’s pre-release traction has reportedly pushed the replacement decision forward.

What the Rs. 124.85 cr. Cume Means for Irumudi

Crossing Rs. 100 cr. worldwide in seven days is a milestone most mid-budget Telugu films chase for a full theatrical cycle.

Irumudi’s pace gets the film to a profitable zone for its producers if the theatrical share terms are in the 35–40% range, which is standard for mass entertainers headlined by a star of Ravi Teja’s standing.

The real loss is not the lifetime number; it is the lost legs. Replacement at day 7 truncates Irumudi’s weekday hold, which is where south Indian mass films typically extract the second-weekend bump.

The Toxic-in, Irumudi-out pattern at chain theatres suggests the film will now lean on independent single screens in core Ravi Teja territories to extend its run.

Forward Outlook: Two Films, One Exhibition Battle

Theatre allocation in India remains a zero-sum game during peak release windows. With Toxic expanding into the slots vacated by Irumudi, Yash’s film inherits a readymade, high-conviction audience, while Irumudi’s producers will need to recalibrate post-theatrical OTT valuation around a shorter, sharper run.

The Times of India box office data confirms the snapshot, and the next 48 hours will show whether Toxic converts its replaced-screen advantage into the kind of opening day 1 numbers the industry expects from a Yash-starrer. More on BO Yash’s as the story develops.

Verdict: Toxic’s pan-India pull and advance bookings have forced a day 7 screen swap, with Irumudi’s Rs. 124.85 cr. worldwide cume not enough to hold its slots.

Related Articles


Was this article helpful?

Your feedback directly improves future articles on this site.

Follow us on Google News Get real-time updates & exclusive tech coverage
Follow

Leave a Reply

Your email address will not be published. Required fields are marked *